VALENCIENNES, France–(BUSINESS WIRE)–Orano Med has inaugurated Europe’s first industrial-scale pharmaceutical facility dedicated to the production of lead-212-based radioligand therapies.
Orano Med Inaugurates ATLab Valenciennes, Europe’s First Industrial Facility Dedicated to the Production of Lead-212-Based Targeted Alpha Therapies
Share This Story, Choose Your Platform!
About the Author:
Leave A Comment
You must be logged in to post a comment.